NicOx asks for COB investigation on share dealing

NicOx, a French pharmaceutical firm, has asked the Commission des Opérations de Bourse (COB), the French securities regulator, to investigate heavy volumes of share trading in its stock ahead of a release giving results from the testing of a new drug.

The company said in a statement that it has requested an investigation "regarding transactions in its stock during the weeks preceding the press release issued by NicOx and AstraZeneca on February 18, 2003".

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump